Drug Approval | October 06, 2025
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
The new site enables end-to-end production of viral vector gene therapies
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Subscribe To Our Newsletter & Stay Updated
